Results 111 to 120 of about 60,004 (165)

Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein. [PDF]

ACS Omega, 2022
Rehman S, Bishnoi S, Roy R, Kumari A, Jayakumar H, Gupta S, Kar P, Pattnaik AK, Nayak D.   +8 more
europepmc   +1 more source

A novel vesicular stomatitis virus armed with IL-2 mimic for oncolytic therapy. [PDF]

Virol Sin
Wu M, Wang Y, Wu C, Huang H, Zhou X, Wang J, Xiong S, Dong C.   +7 more
europepmc   +1 more source

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus. [PDF]

Front Immunol, 2023
Alkayyal AA, Ajina R, Cacciabue M, Alkayyal AA, Saeedi NH, Hussain Alshehry T, Kaboha F, Alotaibi MA, Zaidan N, Shah K, Alroqi F, Bakur Mahmoud A.   +11 more
europepmc   +1 more source

Corrigendum: A vesicular stomatitis virus-based African swine fever vaccine prototype effectively induced robust immune responses in mice following a single-dose immunization. [PDF]

Front Microbiol
Ma Y, Shao J, Liu W, Gao S, Peng D, Miao C, Yang S, Hou Z, Zhou G, Qi X, Chang H.   +10 more
europepmc   +1 more source

Vesicular Stomatitis Virus Isolated from a Bovine Brain Sample in Costa Rica. [PDF]

Microbiol Resour Announc, 2022
León B, Cordero-Solorzano JM, Rodríguez L, Jiménez C.   +3 more
europepmc   +1 more source

Erratum: An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development. [PDF]

Mol Ther Methods Clin Dev
Schimek A, Ng JKM, Basbas I, Martin F, Xin D, Saleh D, Hubbuch J.   +6 more
europepmc   +1 more source

Single-Dose Treatment With Vesicular Stomatitis Virus-Based Ebola Virus Vaccine Expressing Ebola Virus-Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease. [PDF]

J Infect Dis, 2023
O'Donnell KL, Callison J, Feldmann H, Hoenen T, Marzi A.   +4 more
europepmc   +1 more source

Protective Efficacy of Lyophilized Vesicular Stomatitis Virus-Based Vaccines in Animal Model. [PDF]

Emerg Infect Dis
Salawudeen A, Soule G, Tailor N, Klassen L, Audet J, Sloan A, Deschambault Y, Safronetz D.   +7 more
europepmc   +1 more source

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease. [PDF]

Front Immunol, 2023
Monath TP, Nichols R, Feldmann F, Griffin A, Haddock E, Callison J, Meade-White K, Okumura A, Lovaglio J, Hanley PW, Clancy CS, Shaia C, Rida W, Fusco J.   +13 more
europepmc   +1 more source

Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies. [PDF]

Virol J
Wei J, Zhang H, Pei J, Yang Q, Wang Y, Jin X, Liu H, Zhang L, Ma H, Cheng L, Dong Y, Lei Y, Bai Y, Xu Z, Yu P, Zhang F, Ye W.   +16 more
europepmc   +1 more source